Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rifaximin”

165 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 165 results

Post-approval studies (Phase 4)Study completedNCT03077217
What this trial is testing

Low-dose Rifaximin in the Treatment of Covert Hepatic Encephalopathy

Who this might be right for
Covert Hepatic Encephalopathy
Shanghai Changzheng Hospital 40
Post-approval studies (Phase 4)UnknownNCT03987893
What this trial is testing

PEG3350 in ACLF With Hepatic Encephalopathy

Who this might be right for
Hepatic EncephalopathyAcute-On-Chronic Liver Failure
Post Graduate Institute of Medical Education and Research, Chandigarh 60
Large-scale testing (Phase 3)UnknownNCT03185611
What this trial is testing

Effectiveness of Rifaximin Combined With Thiopurine on Preventing Postoperative Recurrence in Crohn's Disease

Who this might be right for
Crohn Disease
Sixth Affiliated Hospital, Sun Yat-sen University 120
Post-approval studies (Phase 4)Looking for participantsNCT06312683
What this trial is testing

Rifaximin for the Secondary Prevention of Recurrent Pouchitis

Who this might be right for
Pouchitis
University of North Carolina, Chapel Hill 16
Testing effectiveness (Phase 2)Looking for participantsNCT04043897
What this trial is testing

Efficacy and Safety of Oral Rifaximin in Patients With Active Microscopic Colitis

Who this might be right for
Microscopic Colitis
Eugene F Yen, MD 10
Large-scale testing (Phase 3)Ended earlyNCT00364689
What this trial is testing

RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial

Who this might be right for
Hepatic Encephalopathy
University of Miami 13
Testing effectiveness (Phase 2)Study completedNCT02124512
What this trial is testing

Blood Lipopolysaccharide (LPS) Rifaximin Study

Who this might be right for
ObeseInsulin ResistanceMetabolic Syndrome
Philip Kern 12
Not applicableUnknownNCT01676597
What this trial is testing

Efficacy of Pentoxifylline and Rifaximin Combination in Pentoxifylline Refractory Clinical and Subclinical Hepatopulmonary Syndrome

Who this might be right for
Hepatopulmonary Syndrome
Institute of Liver and Biliary Sciences, India 80
Testing effectiveness (Phase 2)Study completedNCT01069133
What this trial is testing

Study of Rifaximin in Minimal Hepatic Encephalopathy

Who this might be right for
Minimal Hepatic Encephalopathy
Hunter Holmes Mcguire Veteran Affairs Medical Center 20
Testing effectiveness (Phase 2)Ended earlyNCT04254549
What this trial is testing

Rifaximin in Patients With Diabetic Gastroparesis

Who this might be right for
Crohn DiseaseDiabetic Gastroparesis
Mayo Clinic 5
Very early researchLooking for participantsNCT07185932
What this trial is testing

Efficacy and Safety of Rifaximin in Treating MAFLD

Who this might be right for
Metabolic-associated Fatty Liver Disease
Shanghai Changzheng Hospital 40
Large-scale testing (Phase 3)UnknownNCT03658993
What this trial is testing

Rifaximin-treatment of Collagenous Colitis

Who this might be right for
Collagenous Colitis
Bonderup, Ole K., M.D. 50
Testing effectiveness (Phase 2)Ended earlyNCT04249622
What this trial is testing

Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+18 more
Mayo Clinic 20
Testing effectiveness (Phase 2)Looking for participantsNCT06727422
What this trial is testing

Efficacy of Rifaximin With NAC in IBS-D

Who this might be right for
IBS (Irritable Bowel Syndrome)IBS-D (Diarrhea-predominant)
Mark Pimentel, MD 225
Large-scale testing (Phase 3)Study completedNCT03695705
What this trial is testing

Rifaximin and Norfloxacin for Prevention of SBP in Adults With Decompensated Cirrhosis

Who this might be right for
Cirrhosis, Liver
Post Graduate Institute of Medical Education and Research, Chandigarh 142
Post-approval studies (Phase 4)WithdrawnNCT01654939
What this trial is testing

Impact of an Antibiotic (Rifaximin) on Liver Scarring in HIV-Infected Patients With Liver Disease

Who this might be right for
HIVHepatitis C
Douglas T. Dieterich
Large-scale testing (Phase 3)Study completedNCT02498418
What this trial is testing

Study Comparing Rifaximin With Xifaxan 200 mg in Traveler's Diarrhea

Who this might be right for
Diarrhea
Actavis Inc. 739
Large-scale testing (Phase 3)UnknownNCT02508623
What this trial is testing

Effect of Administration of Rifaximin on the Portal Pressure of Patients With Liver Cirrhosis and Esophageal Varices

Who this might be right for
Liver CirrhosisPortal Hypertension
University of Padova 60
Large-scale testing (Phase 3)Study completedNCT03124199
What this trial is testing

Rifaximin Associated With Classic Triple Therapy for the Eradication of Helicobacter Pylori Infection

Who this might be right for
Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa 40
Testing effectiveness (Phase 2)UnknownNCT02931123
What this trial is testing

A RCT COMPARING LACTULOSE AND RIFAXIMIN ASSOCIATED WITH A VEGETABLE DIET IN THE PREVENTION OF POST-TIPS OVERT HEPATIC ENCEPHALOPATHY

Who this might be right for
Cirrhotic Patients Undergoing TIPS Placement
University of Roma La Sapienza 58
Next Page